• OPEN AN ACCOUNT
Indian Indices
Nifty
25,423.60 93.35
(0.37%)
Sensex
83,013.96 320.25
( 0.39%)
Bank Nifty
55,727.45 234.15
( 0.42%)
Nifty IT
36,750.25 303.10
( 0.83%)
Global Indices
Nasdaq
46,015.42 236.51
(0.52%)
Dow Jones
6,617.88 9.88
(-0.15%)
Hang Seng
45,342.39 552.01
(1.23%)
Nikkei 225
9,228.11 19.74
(0.21%)
Forex
USD-INR
88.02 0.00
(0.00%)
EUR-INR
104.02 0.00
(0.00%)
GBP-INR
120.02 0.00
(0.00%)
JPY-INR
0.60 0.00
(0.00%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
101.444166
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
78.05
388752.25
EPS(TTM)
Face Value()
Div & Yield %
20.76
1
0.99
 

Indokem Ltd - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 30Th June 2025 And Closure Of Trading Window
Jul 31,2025
Indokem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter ended 30th June 2025. In view of this as per the Companys Code of Conduct to regulate monitor and report trading by insiders adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and for the purpose of the consideration of the financial results the trading window of the Company has been closed since 1st July 2025 and the same shall open 48 hours after declaration of Financial results of the Company.